v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net Loss $ (1,086,597) $ (725,660)
Adjustments to reconcile net loss to cash used in operations:    
Depreciation 11,203 13,446
Amortization 35,634 35,634
Stock issued for services 24,024 338
Discount on convertible debt 9,900
Loss on conversion of notes payable 13,593
Changes in operating assets and liabilities    
Decrease (increase) in accounts receivable 217 (63,241)
Increase in inventory (246) (4,061)
Increase in other current assets (5,340) (4,074)
Increase in accounts payable and accrued expenses 414,359 250,302
Net cash used in operating activities (606,746) (473,823)
Cash flows from investing activities:    
Purchase of property and equipment (10,335)
Investment in unconsolidated investee (1,000)
Net cash used in investing activities (11,335)
Cash flows from financing activities:    
Proceeds from sale of common stock 283,000 21,000
Proceeds from issuance of convertible notes payable 95,000
Proceeds from sale of interest in variable interest entity, related party 260,000 650,000
Payments made on notes payable (7,500) (10,000)
Net cash provided by financing activities 535,500 756,000
Net (decrease) increase in cash and cash equivalents (71,246) 270,842
Cash and cash equivalents, beginning of period 108,035 5,163
Cash and cash equivalents, end of period 36,789 276,005
Supplemental cash flow information:    
Interest paid 1,515
Cash paid for income taxes
Schedule of Non-Cash Investing and Financing Activities:    
Issuance of notes payable for accrued directors fees 38,000 76,000
Issuance of notes payable for accrued base salary $ 115,542 483,933
Issuance of notes payable for accounts payable, related parties   74,700
Issuance of common stock as consideration for note payable   $ 10,456